$STML
Stemline Therapeutics to be Acquired for $11.50/Share Cash and Up to $1/Share in Contingent Value Right by Menarini Group
https://t.co/aCfO23iJYQ

#daytrade #daytrading #stocks #stockmarketnews #stockstowatch